Back to Trades
Shanmugam Muthusamy
HEAD OF R&DCOO-NOVITIUM OPSDirectorCIK 0001870913
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 4
- Companies
- 1
- Active
- 2025–2026
Shanmugam Muthusamy, HEAD OF R&D, COO-NOVITIUM OPS, Director, has filed 3 SEC reports (2025–2026), all concentrated in ANI PHARMACEUTICALS INC (ANIP), totaling $18.7M in disclosed volume. Weighing $0 bought versus $17.9M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Mar 2 | ANIP ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS, Director | Grant | $857.6K |
| Aug 22 | ANIP ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS, Director | Sell | $9.0M |
| Aug 18 | ANIP ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS, Director | Sell | $8.8M |
3 filings